✦ LIBER ✦

Clinical significance of antibodies to interferon beta therapy in patients with relapsing–remitting multiple sclerosis

✍ Scribed by Klaus Bendtzen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical importance of neutralising anti

✍ Per Soelberg Sorensen; Christian Ross; Katja Maria Clemmesen; Klaus Bendtzen; Je 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 129 KB

Predictive factors of neutralizing antib

✍ R. Lanzillo; G. Orefice; A. Prinster; G. Ventrella; R. Liuzzi; V. Scarano; C. Fl 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 174 KB

Managing side effects of interferon-beta

✍ Frederick E. Munschauer III; Revere Philip Kinkel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 808 KB

Neurotrophic factors in relapsing remitt

✍ Marcella Caggiula; Anna Paola Batocchi; Giovanni Frisullo; Francesco Angelucci; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 124 KB

A phase I clinical trial of human recomb

✍ J.I. Greenstein; R.L. Knobler; K.P. Johnson; S.G. Marcus; H.S. Panitch; F.D. Lub 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Predictors of long–term clinical respons

✍ V. Tomassini; A. Paolillo; P. Russo; E. Giugni; L. Prosperini; C. Gasperini; G. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 261 KB